Sydänkeskus TO2

Julkaisut 2013
Publications 2013

Lisätietoja julkaisusta saa klikkaamalla sen numeroa.
For full details, please click the number in front of the publication.

1 Ahola T. Antihypertensive Drug Therapy in Finland - Utilization of Antihypertensive Medication, Control of Blood Pressure and Achievable Reduction of Cardiovascular Morbidity with Intensified Treatment.
2 Airaksinen J et al., inventor. Method and apparatus for determining information indicative of cardiac malfunctions and abnormalities WO 2013/160538 A1.
3 Airaksinen J et al., inventor. Method and apparatus for determining information indicative of cardiac malfunctions and abnormalities WO 2013/160537 A1.
4 Airaksinen KEJ et al. Thromboembolic complications after cardioversion of acute atrial fibrillation: The FinCV (Finnish CardioVersion) Study.
5 Airaksinen KEJ et al. Safety of pacemaker and implantable cardioverter-defibrillator implantation during uninterrupted warfarin treatment - The FinPAC study.
6 Airaksinen KEJ et al. Cardioversion in acute atrial fibrillation without anticoagulation.
7 Annala AP et al. Vascular healing early after titanium-nitride-oxide-coated stent implantation assessed by optical coherence tomography.
8 Arola OJ et al. Feasibility and cardiac safety of inhaled Xenon in combination with therapeutic hypothermia following out-of-hospital cardiac arrest.
9 Badeau RM et al. Systematic metabolic markers and myocardial glucose uptake in type 2 diabetic and coronary artery disease patients treated for 16 weeks with rosiglitazone, a PPAR agonist.
10 Birck MM et al. Endothelial cell death and intimal foam cell accumulation in the coronary artery of infected hypercholesterolemic minipigs.
11 Boström P et al. Localization of decorin gene expression in normal human breast tissue and in benign malignant tumors of the human breast .
12 Edvardsen T et al. The year 2012 in the European Heart Journal-Cardiovascular Imaging: Part I.
13 Eerola A et al. Synnynnäistä sydänvikaa sairastavien aikuispotilaiden seurantasuositus.
14 Eerola K et al. Lentivirus mediated alpha-melanocyte stimulating hormone overexpression in the hypothalamus decreases diet induced obesity in mice.
15 Grönberg T et al. Arrhythmic complications after electrial cardioversion of acute atrial fibrillation: The FinCV study .
16 Gunn JM et al. Comparison of the osteoconductive properties of three particulate bone fillers in a rabbit model: Allograft, calcium carbonate (BiocoralR) and S53P4 bioactive glass.
17 Hietala P et al. Perioperative myocardial infarctions are common and often unrecognized in patients undergoing hip fracture surgery.
18 Honka H et al. Validation of [18F]fluorodeoxyglucose and positron emission tomography (PET) for the measurement of intestinal metabolism in pigs, and evidence of intestinal insulin resistance in patients with morbid obesity.
19 Högnäs G et al. Aneuploidy facilitates oncogenic transformation via specific genetic alterations, including twist2 upregulation.
20 Kahlos K et al. Keuhkovaltimoiden verenpainetauti ja krooninen tromboembolinen keuhkoverenpainetauti.
21 Karjalainen P et al. Neointimal coverage and vasodilator response to titanium-nitride-oxide-coated bioactive stents and everolimus-eluting stents in patients with acute coronary syndrome: insights from the BASE-ACS trial.
22 Kiviniemi T et al. Thrombocytopenia in patients with atrial fibrillation on oral anticoagulation undergoing percutaneous coronary intervention.
23 Knuuti J, Saraste A. Combined functional and anatomical imaging for the detection and guiding the therapy of coronary artery disease .
24 Knuuti J et al. Is cardiac magnetic resonance imaging causing DNA damage?
25 Koistinen J et al. Eteisvärinän torakoskooppinen ablaatiohoito.
26 Kosonen P et al. Intravascular ultrasound assessed incomplete stent apposition and stent fracture in stent thrombosis after bare metal versus drug-eluting stent treatment the Nordic Intravascular Ultrasound Study (NIVUS).
27 Kurki J. Sairaanhoitaja ja lääkehoito.
28 Kytö V et al. The effects of gender and age on occurence of clinically suspected myocarditis in adulthood.
29 Laine M et al. Sydämen läppävikojen hoito katetritekniikalla.
30 Lammintausta A. Effects of Socioeconomic Status and Sociodemographic Features on Cardiovascular Disease. Mortality and Morbidity in Finland.
31 Lehtinen T et al. Feasibility and safety of frequency-domain optical coherence tomography for coronary artery evaluation: a single-center study.
32 Lehtoranta L et al. Maternal hyperglycemia leads to fetal cardiac hyperplasia and dysfunction in a rat model.
33 Maeng M et al. Long-term results after simple versus complex stenting of coronary artery bifurcation lesions: Nordic Bifurcation Study 5-year follow-up results.
34 O'meara E et al. Alternative Imaging Modalities in Ischemic Heart Failure (AIMI-HF) IMAGE HF Project I-A: study protocol for a randomized controlled trial.
35 Pessi T et al. Bacterial signatures in thrombus aspirates of patients with myocardial infarction.
36 Pessi T et al. Response to letters regarding article, "Bacterial signatures in thrombus aspirates of patients with myocardial infarction".
37 Plein S et al. The year 2012 in the European Heart Journal-Cardiovascular Imaging. Part II.
38 Rinne P et al. Alpha-Melanocyte-stimulating hormone regulates vascular NO availability and protects against endothelial dysfunction.
39 Rissanen TT et al. The bottleneck stent model for chronic myocardial ischemia and heart failure in pigs.
40 Romppanen H et al. Stent-oriented versus patient-oriented outcome in patients undergoing early percutaneous coronary intervention for acute coronary syndrome: 2-year report from the BASE-ACS trial.
41 Romppanen H et al. Outcome of ST-elevation myocardial infarction versus non-ST-elevation acute coronary syndrome treated with titanium-nitride-oxide-coated versus everolimus-eluting stents: insights from the BASE-ACS trial.
42 Salomaa V et al. Aging of the population may not lead to an increase in the numbers of acute coronary events: a community surveillance study and modelled forecast of the future.
43 Schlitt A et al. Antiplatelet therapy and anticoagulants.
44 Schlitt A et al. The management of patients with atrial fibrillation undergoing percutaneous coronary intervention with stent implantation: in-hospital-data from the atrial fibrillation undergoing coronary artery stenting study.
45 Tuomainen PO et al. Five-year clinical outcome of titanium-nitride-oxide-coated bioactive stents versus paclitaxel-eluting stents in patients with acute myocardial infarction: Long-term follow-up from the TITAX AMI trial.
46 Ukkonen H et al. Voidaanko aivoverenkierron häiriöitä estää sydämen katetritoimenpiteillä.
47 Utriainen KT et al. Unrecognised obstructive sleep apnoea is common in severe peripheral arterial disease.
48 Uusitalo V et al. The association between coronary flow reserve and development of coronary calcifications: a follow-up study for 11 years in healthy young men.
49 Ylitalo A, Pietilä M. Akuutin ST-nousuinfarktin hoito pallolaajennuksella.

Julkaisutietokanta 12.9.2014 Publications Data Base 12.9.2014